Topics

KOL Perspectives: Histologic Healing in Crohn's disease [Report Updated: 25072018] Prices from USD $2125

04:41 EST 29 Nov 2018 | BioPortfolio Report Blog

KOL Perspectives: Histologic Healing in Crohn's disease


Summary


This KOL Insight briefing focuses on KOLs views of Histologic Healing in Crohn's disease.


Questions topics

Use of histological assessment in clinical trials and practice in Crohn's disease

Extrapolation of UC histology to UC

Barriers to adoption of histology assessment in Crohn's disease

Impact of histological data in therapy choice in Crohn's diseaseViews on use of Geboes as an endpoint in Crohn's disease

Views on Phase II subanalysis data for filgotinib


Key Highlights


Majority of KOLs state that histologic healing is not used to assess Crohn's disease patients in clinical practice

Main barriers to adoption of histologic healing identified by KOLs include difficulty in accessing meaningful biopsy locations, as well as lack of data surrounding histology as a treatment goal

Data showing moderate correlation between endoscopy and histology in Phase II does not impact on views of filgotinib efficacy.


Scope


The insight briefing is based on Sociable Pharma's analysis of primary research with our IBD key opinion leaders KOLs.


In total, we conducted interviews with 10 KOLs

5 Europebased 5 N. Americabased

Interviews performed during Q2 2018


KOL data is analyzed to produce

Charts summarizing KOL opinions

Chart callouts of key information details

KOL quotes

Summary of KOL reporting trends

Insight from Sociable Pharma's analysts


Reasons to buy


Combines Qualitative semiquantitative insight from key opinion leaders on Histologic Healing in Crohn's disease

Includes insight recommendations from our diseasespecific healthcare analysts

Utilizes independent expert viewpoints to validate the impact of new clinical data emerging trends on management of IBD

Provides costeffective support for your advisory boards, with topics acting as a catalyst for further expert discussion.

Original Article: KOL Perspectives: Histologic Healing in Crohn's disease [Report Updated: 25072018] Prices from USD $2125

NEXT ARTICLE

More From BioPortfolio on "KOL Perspectives: Histologic Healing in Crohn's disease [Report Updated: 25072018] Prices from USD $2125"

Quick Search

Relevant Topics

Complementary and Alternative Medicine
Alternative medicine are whole medical systems that did not fit with conventional medicine as they have completely different philosophies and ideas on the causes of disease, methods of diagnosis and approaches to treatment. Although often overlapping, co...

Crohn's Disease (CD)
Crohn’s disease (CD) is a long-term condition that causes inflammation of the lining of the digestive system.  Inflammation can affect any part of the digestive system, from the mouth to the back passage, but most commonly occurs in the last s...